This is a systematic review on the treatment of lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS). The heterogeneity of the outcome criteria did not allow a meta-analysis of the published evidence. In the last few decades, the therapeutic options for neurogenic bladder dysfunction have broadened. Despite this, no consensus has been reached as to the management of LUTD and LUTS in patients with MS, and the subject remains controversial. Bladder dysfunction is common in MS, affecting 80%-100% of patients during the course of the disease. Several studies have shown that urinary incontinence has a severe effect on patients' quality of life, with 70 % of patients classifying the impact bladder symptoms had on their life as "high" or "moderate." Moreover, the progressive feature of MS makes its treatment complex, since any achieved therapeutic result may be short-lived, with the possibility that symptoms will recur or develop de novo. © Springer Science+Business Media, LLC 2012.

The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review / Tubaro, Andrea; Puccini, Federica; DE NUNZIO, Cosimo; G. A., Digesu; S., Elneil; C., Gobbi; V., Khullar. - In: CURRENT UROLOGY REPORTS. - ISSN 1527-2737. - STAMPA. - 13:5(2012), pp. 335-342. [10.1007/s11934-012-0266-9]

The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.

TUBARO, ANDREA;PUCCINI, FEDERICA;DE NUNZIO, Cosimo;
2012

Abstract

This is a systematic review on the treatment of lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS). The heterogeneity of the outcome criteria did not allow a meta-analysis of the published evidence. In the last few decades, the therapeutic options for neurogenic bladder dysfunction have broadened. Despite this, no consensus has been reached as to the management of LUTD and LUTS in patients with MS, and the subject remains controversial. Bladder dysfunction is common in MS, affecting 80%-100% of patients during the course of the disease. Several studies have shown that urinary incontinence has a severe effect on patients' quality of life, with 70 % of patients classifying the impact bladder symptoms had on their life as "high" or "moderate." Moreover, the progressive feature of MS makes its treatment complex, since any achieved therapeutic result may be short-lived, with the possibility that symptoms will recur or develop de novo. © Springer Science+Business Media, LLC 2012.
2012
botulinum toxin; pelvic floor muscle training; multiple sclerosis; electrical stimulation; lower urinary tract symptoms; neurogenic detrusor overactivity; anticholinergic
01 Pubblicazione su rivista::01a Articolo in rivista
The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review / Tubaro, Andrea; Puccini, Federica; DE NUNZIO, Cosimo; G. A., Digesu; S., Elneil; C., Gobbi; V., Khullar. - In: CURRENT UROLOGY REPORTS. - ISSN 1527-2737. - STAMPA. - 13:5(2012), pp. 335-342. [10.1007/s11934-012-0266-9]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/486637
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 17
social impact